Genetic-Phenotypic Discordance Reveals Distinct Cardiovascular and Mortality Risk at HDL Cholesterol Extremes
Circulation: Genomic and Precision Medicine · 05.11.2026
DOI: 10.1161/circgen.126.005840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, online erschienen am 05.11.2026. Verfasst von Elad Shemesh und 12 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Risk at high-density lipoprotein cholesterol (HDL-C) extremes may reflect genetic predisposition, ancestry, or region, but their relative contributions remain unknown. We characterized extreme HDL-C associations with atherosclerotic cardiovascular disease and mortality, and examined whether genetic-phenotypic discordance identifies risk beyond measured HDL-C. METHODS: Atherosclerotic cardiovascular disease–free participants from UKB (UK Biobank) and All of Us (AoU) with extremely low (2.3 mmol/L; based on standard clinical guidelines) HDL-C were analyzed. A 247-variant polygenic score stratified European ancestry participants at each HDL-C extreme into tertiles; discordant groups had measured HDL-C contradicting genetic predisposition. RESULTS: Among 408 353 UKB and 115 423 AoU participants, extremely low HDL-C was associated with higher atherosclerotic cardiovascular disease (UKB: hazard ratio [HR], 1.33 [95% CI, 1.27–1.39]; AoU: HR, 1.32 [95% CI, 1.08–1.61]) and mortality (UKB: HR, 1.25 [95% CI, 1.20–1.30]; AoU: HR, 1.64 [95% CI, 1.37–1.96]) across ancestries. Extremely high HDL-C was associated with excess mortality in UKB European ancestry (HR, 1.28 [95% CI, 1.19–1.38]), driven by COPD (HR, 2.64 [1.94–3.59]) and lung infections (HR, 2.24 [95% CI, 1.48–3.39]), but not in AoU European ancestry. In UKB, this was confined to genetically discordant high HDL (high-density lipoprotein; polygenic score HDL T1; HR, 1.53 [95% CI, 1.22–1.92]); genetically concordant high HDL showed progressively lower mortality. Genetically discordant low HDL (polygenic score HDL T3) carried higher atherosclerotic cardiovascular disease (UKB: HR, 1.20 [95% CI, 1.08–1.34]; AoU: HR, 1.44 [95% CI, 1.15–1.81]) and mortality (UKB: HR, 1.22 [95% CI, 1.11–1.34]; AoU: HR, 1.75 [95% CI, 1.21–2.54]) than concordant low HDL (polygenic score HDL T1), comparable in magnitude to a 10 mm Hg increment in systolic blood pressure. CONCLUSIONS: Extreme HDL-C levels carry different cardiovascular and mortality risk depending on whether they reflect or contradict genetic predisposition, with additional variation by ancestry and region.
Zitieren
APA
Shemesh, E., Pang, K., Meyre, P. B., Man, A., Graf, J., Wang, S., Li, Y., Beaucage, P., Rocha, G. L. D., Kamal, M., Pigeyre, M., Shapiro, M. D., & Paré, G. (2026). Genetic-Phenotypic Discordance Reveals Distinct Cardiovascular and Mortality Risk at HDL Cholesterol Extremes. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.126.005840
Vancouver
Shemesh E, Pang K, Meyre PB, Man A, Graf J, Wang S, et al. Genetic-Phenotypic Discordance Reveals Distinct Cardiovascular and Mortality Risk at HDL Cholesterol Extremes. Circulation: Genomic and Precision Medicine. 2026. doi:10.1161/circgen.126.005840
BibTeX
@article{Shemesh2026,
author = {Shemesh, Elad and Pang, Keona and Meyre, Pascal B. and Man, Alice and Graf, Josef and Wang, Shuang and Li, YanRan and Beaucage, Pierre and Rocha, Guilherme Luiz Da and Kamal, Michael and Pigeyre, Marie and Shapiro, Michael D. and Paré, Guillaume},
title = {Genetic-Phenotypic Discordance Reveals Distinct Cardiovascular and Mortality Risk at HDL Cholesterol Extremes},
journal = {Circulation: Genomic and Precision Medicine},
year = {2026},
doi = {10.1161/circgen.126.005840}
}
EUVIMED